Trametinib Inhibits the Growth and Aerobic Glycolysis of Glioma Cells by Targeting the PKM2/c-Myc AxisMingjun Gao(Dalian Medical University), Jing Liu(East China University of Science and Technology)Frontiers in PharmacologyOctober 21, 202110.3389/fphar.2021.760055Cited by 38SaveCiteExport RISWatch citationsRelated PapersMachine learning-based prognostic model of lactylation-related genes for predicting prognosis and immune infiltration in patients with lung adenocarcinoma|Cancer Cell International|2024|26Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial|Annals of the Rheumatic Diseases|2025|17